Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Multifunctional Effect of Human Serum Albumin Reduces Alzheimer's Disease Related Pathologies in the 3xTg Mouse Model.

Journal of Alzheimer's disease : JAD - 1 Jan 2016

Ezra Assaf, Rabinovich-Nikitin Inna, Rabinovich-Toidman Polina, Solomon Beka

Abstract excerpt

Alzheimer's disease (AD), the prevalent dementia in the elderly, involves many related and interdependent pathologies that manifests simultaneously, eventually leading to cognitive impairment and death. No treatment is currently available; however, an agent addressing several key pathologies simultaneously has a better therapeutic potential. Human serum albumin (HSA) is a highly versatile protein, harboring...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Albumins
Share to Amyloid beta-Protein Precursor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Blood-Brain Barrier

Share to Cognition Disorders

Share to Drug Delivery Systems

Share to Encephalitis

Share to Neuroblastoma

Share to Presenilin-1

Source

Identifiers

PMID: 26682687
DOI: 10.3233/JAD-150694

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Multifunctional Effect of Human Serum Albumin Reduces Alzheimer's Disease Related Pathologies in the 3xTg Mouse Model.PMID 26682687Read ↗

Multifaceted nanoparticles: emerging mechanisms and therapies in neurodegenerative diseases.Semantic proximity Read ↗

Tau-Targeting Nanoparticles for Treatment of Alzheimer's DiseaseSemantic proximity Read ↗

In Search for the Low-Molecular-Weight Ligands of Human Serum Albumin that Affect its Affinity for Monomeric Amyloid β PeptideSemantic proximity Read ↗

Therapeutic Potential of Arimoclomol Nanomicelles: In Vitro Impact on Alzheimer’s and Parkinson’s Pathology and Correlation with In Vivo Inflammatory ResponseSemantic proximity Read ↗

Therapeutic effect of exogenous hsp70 in mouse models of Alzheimer's disease.Semantic proximity Read ↗

Blood-brain barrier penetrating neprilysin degrades monomeric amyloid-beta in a mouse model of Alzheimer’s diseaseSemantic proximity Read ↗

Nanobody Therapeutics in Alzheimer’s Disease: From Molecular Mechanisms to Translational ApproachesSemantic proximity Read ↗

A sporadic Alzheimer’s blood-brain barrier model for developing ultrasound-mediated delivery of Aducanumab and anti-Tau antibodiesSemantic proximity Read ↗

Alzheimer's Disease and Molecular Chaperones: Current Knowledge and the Future of ChaperonotherapySemantic proximity Read ↗

Enhanced delivery of low-dose of aducanumab via FUS in 5xFAD mice, an AD modelSemantic proximity Read ↗

Targeting Soluble Amyloid-Beta Oligomers With a Novel NanobodySemantic proximity Read ↗

Expression of amyloid-β antibody via AAV of CNS tropism alleviates Alzheimer’s disease in miceSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.